임상 시험 검색 : Ti02 microfine 12.15% Ti02 pigmentary 3% bisoctrizole 10% [V0096 CR (formula RV3131A-MV1166)]
총 1 건
-
Orfagen완전한
이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.
스폰서 및 공동 작업자
- Shanghai High-risk Infants Early Intervention Center
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
- Reina Sofia University Hospital
- Laura Schanberg
- Areteia Therapeutics
- UiT The Arctic University of Norway
- Bureau of Health of Ji County
- The Norwegian Arthroplasty Register
- Olayan-Xefos Family Fund for Breast Cancer Research
- Santa Barbara Cottage Hospital
- Biomapas
- Northern Ostrobothnia District Hospital
- NMS Laboratories
- Beijing Chuiyangliu Hospital
- Comunity pharmacy Lekarne Ptuj
- Nanox International Laboratory (Belgique)
- US federal government
- Synchrophi Systems Ltd
- Zentrum fur Humangenetik Tuebingen
- West of England Academic Health Science Network
- 전체 목록보기
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Algeria
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Brazil
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Ecuador
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Germany
- Contract Research Organizations in Israel
- Contract Research Organizations in Netherlands
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- CRO list by country